Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis.

[1]  C. Elmets,et al.  Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. , 2014, Journal of the American Academy of Dermatology.

[2]  J. C. Jaworski,et al.  Topical Calcineurin Inhibitors and Lymphoma Risk: Evidence Update with Implications for Daily Practice , 2013, American Journal of Clinical Dermatology.

[3]  W. Carr.  Topical Calcineurin Inhibitors for Atopic Dermatitis: Review and Treatment Recommendations , 2013, Pediatric Drugs.

[4]  D. Hémon,et al.  Childhood hodgkin's lymphoma, non‐hodgkin's lymphoma and factors related to the immune system: The escale study (SFCE) , 2011, International journal of cancer.

[5]  M. Sugaya,et al.  Erythrodermic cutaneous T-cell lymphoma: how to differentiate this rare disease from atopic dermatitis. , 2011, Journal of dermatological science.

[6]  K. Rothman,et al.  Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors , 2011, The British journal of dermatology.

[7]  R. Schlienger,et al.  Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K. , 2010, The British journal of dermatology.

[8]  J. Siemiatycki,et al.  History of asthma or eczema and cancer risk among men: a population-based case-control study in Montreal, Quebec, Canada. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[9]  R. Hui,et al.  Association Between Exposure to Topical Tacrolimus or Pimecrolimus and Cancers , 2009, The Annals of pharmacotherapy.

[10]  J. Cerhan,et al.  Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. , 2009, Cancer research.

[11]  R. Schlienger,et al.  Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom. , 2009, The Journal of allergy and clinical immunology.

[12]  N. Undre,et al.  Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis , 2009, The British journal of dermatology.

[13]  J. Mazereeuw-Hautier,et al.  Cutaneous T Cell Lymphoma Complicating Severe Atopic Dermatitis , 2008, Dermatology.

[14]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[15]  J. Cerhan,et al.  The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk , 2007, Cancer Causes & Control.

[16]  J. Kaldor,et al.  Atopy, exposure to pesticides and risk of non‐Hodgkin lymphoma , 2007, International journal of cancer.

[17]  C. Paul,et al.  Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. , 2007, The Journal of investigative dermatology.

[18]  H. Adami,et al.  Atopy and risk of non-Hodgkin lymphoma. , 2007, Journal of the National Cancer Institute.

[19]  L. Thomas,et al.  Aggressive CD30 Large Cell Lymphoma after Cyclosporine Given for Putative Atopic Dermatitis , 2006, Dermatology.

[20]  O. Nyrén,et al.  Incidence of cancer among patients with atopic dermatitis. , 2005, Archives of dermatology.

[21]  N. Undre,et al.  Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis. , 2005, The Journal of investigative dermatology.

[22]  J. Kaldor,et al.  Birth order, atopy, and risk of non-Hodgkin lymphoma. , 2004, Journal of the National Cancer Institute.

[23]  L. Hagmar,et al.  Allergic conditions and risk of hematological malignancies in adults: a cohort study , 2004, BMC public health.

[24]  P. Boyle,et al.  Prior Medical Conditions and Medication use and Risk of non-Hodgkin lymphoma in Connecticut United States Women , 2004, Cancer Causes & Control.

[25]  E. Holly,et al.  Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco. , 2003, American journal of epidemiology.

[26]  W. Ahrens,et al.  Viral infection, atopy and mycosis fungoides: a European multicentre case-control study. , 2003, European journal of cancer.

[27]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[28]  D. Margolis,et al.  The risk of malignancy associated with psoriasis. , 2001, Archives of dermatology.

[29]  J. Rossi,et al.  Environmental Risk Factors for non-Hodgkin's Lymphoma: A Population-based Case–Control Study in Languedoc-Roussillon, France , 2001, Cancer Causes & Control.

[30]  O. Nanni,et al.  Haematopoietic cancer and medical history: a multicentre case control study , 2000, Journal of epidemiology and community health.

[31]  L. Bernstein,et al.  Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County. , 1992, Cancer research.

[32]  J. Fraumeni,et al.  Leukemia, lymphoma, and multiple myeloma following selected medical conditions , 1992, Cancer Causes & Control.

[33]  D. Thaçi,et al.  Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies. , 2010, Clinics in dermatology.

[34]  W. High.  Topical Treatments with Pimecrolimus, Tacrolimus and Medium- to High-Potency Corticosteroids, and Risk of Lymphoma , 2010 .

[35]  J. Ring,et al.  The US FDA ‘Black Box’ Warning for Topical Calcineurin Inhibitors , 2008, Drug safety.

[36]  D. Weisenburger,et al.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. , 2006, Blood.

[37]  C Schmied,et al.  [Epidemiology of atopic dermatitis]. , 1989, Annales de dermatologie et de venereologie.

[38]  I. Lauder,et al.  Non-Hodgkin's lymphoma: case control epidemiological study in Yorkshire. , 1988, Leukemia research.

[39]  R. MacKie,et al.  A case-control study of possible causative factors in mycosis fungoides. , 1987, Archives of dermatology.